Sensus Healthcare (SRTS) announces that the company has resumed purchasing shares of its common stock in open-market transactions under a $3.0 million share repurchase program approved by its Board of Directors and announced in August 2023.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRTS:
- Sensus Healthcare’s Strong Revenue Growth and Strategic Initiatives Justify Buy Rating
- Sensus Healthcare price target raised to $12 from $11 at H.C. Wainwright
- Sensus Healthcare Earnings Call Highlights Robust Growth
- Sensus Healthcare Announces Strong 2024 Financial Results
- Sensus Healthcare reports Q4 EPS 9c, consensus 12c